Your browser doesn't support javascript.
loading
Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study.
Wang, Rui; Zhao, Changming; Jiang, Shuxia; Zhang, Zhaohua; Ban, Chunmei; Zheng, Guiping; Hou, Yan; Jin, Bingjin; Shi, Yannan; Wu, Xin; Zhao, Qiangqiang.
Afiliação
  • Wang R; Department of Hematology, Shandong Second Provincial General Hospital, Jinan, China.
  • Zhao C; Department of Hematology, Shandong Second Provincial General Hospital, Jinan, China.
  • Jiang S; Department of Hematology, The Qinghai Provincial People's Hospital, Xining, China.
  • Zhang Z; Department of Hematology, The Qinghai Provincial People's Hospital, Xining, China.
  • Ban C; Department of Hematology, Hematology Department, The People's Hospital of Liuzhou City, Liuzhou, China.
  • Zheng G; Department of Hematology, The Qinghai Provincial People's Hospital, Xining, China.
  • Hou Y; Department of Hematology, The Qinghai Provincial People's Hospital, Xining, China.
  • Jin B; Department of Pharmacy, The Qinghai Provincial People's Hospital, Xining, China.
  • Shi Y; Department of General Medicine, Ganmei Hospital, Kunming First People's Hospital, Kunming, China.
  • Wu X; Department of Spine Surgery, Third Xiangya Hospital, Central South University, Changsha, China.
  • Zhao Q; Department of Hematology, The Qinghai Provincial People's Hospital, Xining, China.
Front Bioeng Biotechnol ; 10: 1027868, 2022.
Article em En | MEDLINE | ID: mdl-36299285
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça